MEGHAN SULLIVAN, PHD, CMPP
Dr. Sullivan received her PhD from The University of Chicago's committee on Molecular Pathology and Molecular Medicine, where her research focused on the production of cytokines in human pulmonary tissue and their contribution to asthma pathogenesis. While at The University of Chicago, Dr. Sullivan also studied the efficacy of the yearly influenza vaccine and its impact on the B-cell repertoire. Her extensive research in the field of human immunology makes her uniquely suited to working in the rapidly growing field of immuno-therapeutics.
Since graduating, Dr. Sullivan has been involved in numerous publications in the fields of oncology (glioblastoma, head and neck cancer, non-small–cell lung cancer, among others), diabetes, chronic kidney disease, cardiology, and rheumatology. In the field of oncology, she has extensive experience with immuno-oncologic agents, including monoclonal antibodies and small molecule inhibitors. She is a member of the International Society for Medical Publication Professionals and has received the Certified Medical Publication Professional certification. Her expertise includes the development of congress abstracts, posters, and presentations as well as original articles, reviews, gap analyses, and lexicons.